The introduction of anti-amyloid monoclonal antibody therapies for Alzheimer’s disease highlights the growing importance of ARIA (Amyloid-Related Imaging Abnormalities) in clinical practice, encompassing prediction, detection, and management. Addressing ARIA effectively is essential for the safe and successful implementation of these novel treatments.
In this webinar,
PD Dr. med. Piotr Radojewski (Translational Imaging Center Bern and University Institute of Diagnostic and Interventional Neuroradiology, Inselspital, University Hospital Bern) will provide an in-depth overview of current strategies for predicting, detecting, and managing ARIA, with a focus on imaging-based approaches and clinical decision-making.
The webinar is hosted by
Prof. Bogdan Draganski (Inselspital Bern) and offers a platform for expert exchange and discussion, enabling participants to share perspectives and experiences related to ARIA in the context of emerging Alzheimer’s therapies.
Event details:
- Date: 12.02.2026
- Time: 12:00
- Duration: 50 minutes (includes Q&A)
- Language: English
- Location: Online (link to be provided upon registration)
- Costs: Free of charge
Credits
- Schweizerische Vereinigung für Neuropsychologie (SVNP): 1 credit
- Schweizerische Fachgesellschaft für Geriatrie (SFGG): 1 credit
- Schweizerische Neurologische Gesellschaft (SNG): 1 credit
- Schweizerische Gesellschaft für Alterspsychiatrie und Alterspsychotherapie (SGAP-SPPA): 1 credit
Secure your spot
Fill out the registration form below and you will receive a link to access the webinar.